ContextVision AB (publ) (OSL: CONTX)

Market Cap	369.82M
Revenue (ttm)	140.63M
Net Income (ttm)	22.57M
Shares Out	77.37M
EPS (ttm)	0.29
PE Ratio	16.56
Forward PE	16.63
Dividend	n/a
Ex-Dividend Date	n/a

Volume	25,918
Open	4.880
Previous Close	4.890
Day's Range	4.780 - 4.930
52-Week Range	4.520 - 9.200
Beta	1.12
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 7, 2024

About ContextVision AB

ContextVision AB (publ), a medical technology software company, provides image analysis and imaging for medical systems in Asia, Europe, and America. The company offers image enhancement software for 2D/3D/4D ultrasound, radiography, magnetic resonance imaging (MRI), and veterinary uses. Its products include Rivent that offers image enhancement and visualization solutions for ultrasound systems for women’s health, general imaging, cardiovascular, and point of care applications; Rivent Mobile, a 2D image enhancement product for handheld units; a...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1983
• Employees: 40
• Stock Exchange: Oslo Børs
• Ticker Symbol: CONTX

Financial Performance

In 2023, ContextVision AB's revenue was 132.60 million, an increase of 7.62% compared to the previous year's 123.21 million. Earnings were 32.73 million, an increase of 13.68%.

Financial numbers in SEK